A team of New Jersey researchers reviewed the evidence for the impact of robotic exoskeleton devices on recovery of ambulation among individua5ls with acquired brain injury, laying out a systematic framework for the evaluation of such devices that is needed for rigorous research studies. The open access article, “Lower extremity robotic exoskeleton devices for overground ambulation recovery in acquired brain injury — A review”, was published May 25, 2023 in Frontiers in Neurorobotics.

The authors are Kiran Karunakaran, PhD, Sai Pamula, Caitlyn Bach, Soha Saleh, PhD, and Karen Nolan, PhD, from the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation, and Eliana Legelen, MA, from Montclair State University.

Acquired brain injury was defined as cerebral palsy, traumatic brain injury or stroke. The review focused on 57 published studies of overground training in wearable robotic exoskeleton devices. The manuscript provides a comprehensive review of clinical and pre-clinical research on the therapeutic effects of various devices.

“Despite rapid progress in robotic exoskeleton design and technology, the efficacy of such devices is not fully understood. This review lays the foundation to understand the knowledge gaps that currently exist in robotic rehabilitation research,” said lead and corresponding author Dr. Karunakaran, citing the many variables among the devices and the clinical characteristics of acquired brain injury. “The control mechanisms vary widely among these devices, for example, which has a major influence on how training is delivered,” she added. “There’s also wide variability in other factors that affect the trajectory of recovery, including the timing, duration, dosing, and intensity of training in these devices.”

Developing a framework for future research requires a comprehensive approach based on diagnosis, stage of recovery, and domain, according to co-author Karen J. Nolan, PhD, associate director of the Center for Mobility and Rehabilitation Engineering Research and director of the Acquired Brain Injury Mobility Laboratory. “Through this approach, we will find the optimal ways to use lower extremity robotic exoskeletons to improve mobility in individuals with acquired brain injury,” said Dr. Nolan.

“It’s important to note that our review is unique in presenting both the downstream (functional, biomechanical, physiological) and upstream (cortical) evaluations after rehabilitation using various robotic devices for different types of acquired brain injury,” Dr. Karunakaran noted. “Each device needs to be evaluated by domain in each population and throughout all stages of recovery. This is the necessary scope for determining the response to treatment.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

what is 8 in addition to 3?

Explore More

NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from

A new type of degenerative brain disease underlying dementia is very common among the oldest old

A new type of degenerative brain disease, limbic-predominant age-related TDP-43 encephalopathy (LATE), was recognised just a decade or so ago, and remains relatively unknown. In the disease, the TDP-43 protein

People with epilepsy live shorter lives

On average, people with epilepsy live 10-12 years fewer than those who do not have the condition. Excess mortality is particularly pronounced among people with epilepsy and mental disorders. This